How do you solve two training problems at the same time? For Peter Mckie and Dr Anthony Lewis the answer was iPads, a yellow bag and some very clever software to simulate patient monitors and defibrillators.
Dr Anthony Lewis
Dr Anthony Lewis is an anaesthetist who has been involved in medical education for over a decade and has worked as a retrieval medicine specialist at Sydney HEMS. Originally from Wales, he now lives in Australia and as well as leading research and development at iSimulate, he continues to create and run medical education courses and work as an anaesthetist in various hospitals. Following the acquisition of iSimulate by 3B Scientific, Anthony continues in his role as Medical Director for iSimulate.
Peter Mckie worked as an intensive care paramedic before establishing Parasol EMT in Canberra, a healthcare training company with offices throughout Australia. He was the Chairman of the ACT Australian Resuscitation Council for 20 years and regularly teaches on Advanced Life Support courses. As the CEO of iSimulate, Peter used his extensive experience in healthcare, business and education to full effect. Following the acquisition of iSimulate by 3B Scientific, Peter continues in his role as Head of iSimulate Strategy and Innovation.
Bobby Syed is an entrepreneur at heart, with a focus on sales and marketing. Based in New York, Bobby has become a local leader and expert in sales, marketing, business development, exporting, and establishing new companies internationally. As President of the Americas for iSimulate, Bobby used his vast knowledge in emergency services and corporate markets to focus on business growth and establishing iSimulate as a market leader in the medical simulation industry for patient monitoring, vital signs simulation and defibrillation training in EMS and ALS education. Following the acquisition of iSimulate by 3B Scientific, Bobby continues in his role as Chief Operating Officer for iSimulate.
Although Anthony, Peter and Bobby have a common passion in delivering high quality clinical education, their diverse backgrounds have allowed them to bring unique strengths to iSimulate. Adding the global network of 3B Scientific companies to the already strongly positioned team of iSimulate will allow the companies to grow and to advance medical and healthcare together.
iSimulate is now part of the 3B Scientific Group
In January 2020, 3B Scientific, a portfolio company of J.H. Whitney Capital Partners, LLC and the world’s leading manufacturer and marketer of anatomical models and medical simulation products for healthcare and patient education, announced that it has entered into an agreement to acquire iSimulate Pty. Ltd. (“iSimulate”), a leader in clinical education technology offering smart and cost effective medical simulation solutions.“iSimulate has revolutionized simulation training in healthcare through its creative simulation solutions including ALSi, REALITi, CTGi and AURiS,” said Todd Murray, CEO of 3B Scientific. “We are extremely excited to further develop the 3BScientific platform and add the great products and people of iSimulate to our company. Our 3B Scientific global distribution footprint including fourteen commercial locations is uniquely positioned to further support and accelerate the growth of iSimulate products worldwide.”iSimulate CEO Peter McKie added, “We are proud of the progress we have made with our company and Anthony, Bobby and I decided that the 3B Scientific team would be the best partner for us to expand and grow the business in the years to come. We are excited for the next step in our journey and appreciate the support from our customers worldwide. We look forward to working closely with Todd and his team.”After the closing, Peter McKie, Anthony Lewis and Bobby Syed will remain active in the company and continue to drive the business plan for iSimulate. A significant emphasis for strong growth and the development of the product pipeline lies in the active collaboration from and partnership with the experts from 3B Scientific and Cardionics. iSimulate operations will remain unchanged and will continue to be based in both Canberra, Australia and Albany, NY.The healthcare simulation market has experienced significant growth in the past decade and is estimated to reach USD $2.27 Billion by 2021, according to a 2016 MarketsandMarkets report.The acquisition is anticipated to be consummated in the first quarter of 2020.Gibson, Dunn and Crutcher LLP and Clayton Utz are serving as legal advisors to 3B Scientific and J.H. Whitney Capital Partners, LLC. Schwartz Heslin Group, Inc. is acting as a financial advisor to iSimulate, and Pepper Hamilton LLP and MinterEllison are serving as legal advisors to iSimulate.
iSimulate was founded by Peter McKie and Anthony Lewis in 2011 with the mission of providing effective, reliable and realistic simulation tools. The solution they developed together has revolutionized healthcare simulation training worldwide.
About the 3B Scientific Group
3B Scientific was founded in 1948 in Hamburg, Germany and has grown to be the world’s leading manufacturer of anatomical models and a global supplier of
innovative and reliable medical simulators for basic, advanced and specialty skill training. Today, 3B Scientific is represented in over 100 countries worldwide with the mission to advance medical and healthcare delivery through the quality, breadth and global reach of relevant educational and simulation products. To learn more about 3B Scientific, visit: www.3bscientific.com.
About J.H. Whitney Capital Partners, LLC
J.H. Whitney, established in 1946 by industrialist and philanthropist, John Hay “Jock” Whitney, was one of the first U.S. private equity firms and is often credited with pioneering the development of the private equity industry. Today, J.H. Whitney remains a leader in the private equity industry, having invested in over 400 companies since formation, and currently manages approximately $1.0 billion in private capital. J.H. Whitney remains privately owned by its investing professionals and its main activity is to provide private equity capital to small and middle market companies with strong growth prospects in a number of industries including consumer, healthcare, and specialty manufacturing. To learn more about J.H. Whitney, visit: http://www.whitney.com.